Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1/2 6Phase 1 5Phase NA 1Phase 3 1Phase 2/3 1

Status

Unknown 2Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 383Carcinoma, Renal Cell 210Urinary Bladder Neoplasms 117Carcinoma, Non-Small-Cell Lung 99Melanoma 78Kidney Neoplasms 74Carcinoma, Transitional Cell 73Neoplasm Metastasis 72Ovarian Neoplasms 71Breast Neoplasms 69Neoplasms 64Colorectal Neoplasms 59Squamous Cell Carcinoma of Head and Neck 50Stomach Neoplasms 49Uterine Cervical Neoplasms 44Pancreatic Neoplasms 44Triple Negative Breast Neoplasms 39Lung Neoplasms 35Esophageal Neoplasms 32Non-Muscle Invasive Bladder Neoplasms 31Endometrial Neoplasms 30Carcinoma, Hepatocellular 29Sarcoma 28Small Cell Lung Carcinoma 25Head and Neck Neoplasms 25Colonic Neoplasms 19Wilms Tumor 15Metastatic Castration-resistant Prostate Cancer 14Glioblastoma 14Carcinoma, Merkel Cell 14

Interventions

abiraterone 1VT-464 1Cyclophosphamide 1Control Groups 1Carboplatin 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Castration-resistant Prostate Cancer × Genitourinary × Clear all
NCT07259213 2026-04-01

RAD402

Radiopharm Theranostics, Ltd

Phase 1/2 Recruiting
73 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT05549778 2023-07-11

PEACe

Jiangnan University

Phase 1/2 Completed
12 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04839055 2021-04-09

CoA-CRPC

Jiangnan University

Phase 1/2 Unknown
50 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT03514836 2021-02-01

A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer

Sotio Biotech Inc.

Phase 1/2 Terminated
5 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04148885 2019-11-04

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 1/2 Unknown
44 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT02361086 2019-02-01

A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Innocrin Pharmaceutical

Phase 1/2 Completed
21 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡